Differential effects of darifenacin and tolterodine on heart rate (HR) and heart rate variability (HRV): A three-way crossover, randomised study in healthy subjects

Olshansky B1, Spierings E2, Brum J3, Egermark M4, Mongay L5, Seifu Y5, Facchinei S5

Abstract Category

Neurourology: Clinical

Abstract 441
Non-Discussion Posters
Scientific Non Discussion Poster Session 32
1. University of Iowa Hospitals, 2. MedVadis Research Corporation, 3. Procter & Gamble Pharmaceuticals, 4. Novartis Pharma, 5. Novartis